Vyluma has announced that the National Medical Products Administration (NMPA) of China has accepted ...
read moreAI Optics, a medical device company specializing in artificial intelligence-driven ophthalmic soluti...
read moreThe European Medicines Agency (EMA) has issued its third Letter of Support to the Macustar consortiu...
read moreHarrow, a leading eye care pharmaceutical company in North America, has announced the launch of Harr...
read moreSeaBeLife has announced promising in vivo preclinical results for its investigational drug SBL03, an...
read moreViralgen and Axovia Therapeutics have announced a strategic collaboration to develop and manufacture...
read moreApellis Pharmaceuticals has announced that the Therapeutic Goods Administration (TGA) of Australia h...
read moreNorlase, a global leader in ophthalmic laser technology, has announced the commercial launch of LYNX...
read moreMERIT, a global provider of clinical trial endpoint and technology services, has announced the acqui...
read moreOutlook Therapeutics shared results from the NORSE EIGHT clinical trial at the Hawaiian Eye and Reti...
read more